Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Autolus Therapeutics (AUTL) over the last 8 years, with Q3 2025 value amounting to 0.07.

  • Autolus Therapeutics' Asset Utilization Ratio rose 51536.67% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year increase of 51536.67%. This contributed to the annual value of 0.02 for FY2024, which is 34549.14% up from last year.
  • Per Autolus Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.07 for Q3 2025, which was up 51536.67% from 0.04 recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Asset Utilization Ratio registered a high of 0.75 during Q3 2021, and its lowest value of 0.0 during Q2 2021.
  • Over the past 5 years, Autolus Therapeutics' median Asset Utilization Ratio value was 0.02 (recorded in 2023), while the average stood at 0.16.
  • Examining YoY changes over the last 5 years, Autolus Therapeutics' Asset Utilization Ratio showed a top increase of 2123328.73% in 2022 and a maximum decrease of 9883.72% in 2022.
  • Autolus Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.67 in 2021, then plummeted by 97.56% to 0.02 in 2022, then tumbled by 73.55% to 0.0 in 2023, then skyrocketed by 189.51% to 0.01 in 2024, then skyrocketed by 487.73% to 0.07 in 2025.
  • Its Asset Utilization Ratio stands at 0.07 for Q3 2025, versus 0.04 for Q2 2025 and 0.01 for Q1 2025.